Protective effects of melatonin against caustic esophageal burn injury in rats.
Caustic ingestion is one of the most life-threatening events in the pediatric age group, which requires the immediate management and subsequent treatment of its most significant complication, i.e. alterations in esophageal structure. We investigated whether melatonin could reduce the esophageal burn damage induced by sodium hydroxide. It was assumed that melatonin could be effective because of its function as a direct free radical scavenger, its antioxidative actions and its ability to diminish tissue hydroxyproline (HP) levels. Esophageal burns were induced in male rats by the administration of 10% sodium hydroxide. Lipid peroxidation (LPO) products were then measured at the following times: 0, 1, 6, 24, 48 and 72 hr after treatment. Tissue HP concentrations in the injured area were assessed at 14 days after the administration of sodium hydroxide. The groups received either systemic melatonin or normal saline. There were two, non-ischemic, sham control groups treated with or without melatonin. LPO products, malondialdehyde (MDA) and 4-hydroxyalkenal (4-HDA), increased immediately after the administration of sodium hydroxide; this indicates the participation of free radicals in the development of damage. Melatonin diminished the oxidative response and the amount of HP in the late phase of the lesion. Melatonin reduced oxidative damage in the early phase of the esophageal burns induced by sodium hydroxide.
Larios-Arceo
F
F
Servicio de Cirugía Pediátrica, Hospital de Pediatría, IMSS, Guadalajara, Jalisco, México.
Ortiz
G G
GG
Huerta
M
M
Leal-Cortés
C
C
Saldaña
J A
JA
Bitzer-Quintero
O K
OK
Rodríguez-Reynoso
S
S
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002057:Burns, Chemical / Q000188:drug therapy* / Q000209:etiology; D004947:Esophagus / Q000187:drug effects* / Q000293:injuries / Q000378:metabolism; D006909:Hydroxyproline / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000494:pharmacology*; D020011:Protective Agents / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012972:Sodium Hydroxide / Q000633:toxicity
D000975:Antioxidants; D020011:Protective Agents; D008315:Malondialdehyde; D012972:Sodium Hydroxide; D008550:Melatonin; D006909:Hydroxyproline